LONDON (UK), February 2020 — Early-stage research in rats, by a group of scientists led by Imperial College London, revealed two existing medications that can boost the body's own repair machinery by triggering the release of stem cells from the bone marrow.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
UTRECHT (NL), February 2020 — Whereas the CRISPR-Cas technology developed in 2012 cuts out a defect in a gene and replaces it with a new piece, the latest CRISPR technology works differently. The aim is to repair the error in the DNA without cutting it.
BOSTON, MA (US), February 2020 — Deep within the lining of the human intestine lies the source of the organ’s ability to renew itself and recover from damage.
PORTO ALEGRE (BR), February 2020 — Medulloblastoma, the most common brain cancer in children, may arise from biological abnormalities in neural stem cells or neuronal precursors during embryonic development.
RIO DE JANEIRO (BR), February 2020 — Astrocytes are neural cells with many important functions in the nervous system. The inflammation of these cells occurs in brain infections and neurodegenerative disorders, a process called astrogliosis.
NUTLEY, NJ (US), February 2020 — Reversing runaway inflammation in the bone marrow could lead to major breakthroughs in treatments for some blood cancers, according to a new publication by scientists at Hackensack Meridian Health's Center for Discovery and Innovation (CDI).
UTRECHT (NL), February 2020 — Researchers from the Hubrecht Institute and the Max Planck Institute have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.
STANFORD, CA (US), February 2020 — Every cell in our body has a computer-like control system that sends biological signals through thousands of circuits to monitor the cell's needs and regulate its responses.
KOBE (JP), February 2020 — Researchers at Kobe University's Graduate School of Medicine have developed the world's first congenital pituitary hypoplasia (CPH) model using patient-derived induced pluripotent stem cells (iPSCs).